Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 11—November 2024
Dispatch

Computerized Decision Support Systems Informing Community-Acquired Pneumonia Surveillance, France, 2017–2023

Tristan Delory1Comments to Author , Josselin Le Bel1, Raphaëlle Métras, Caroline Guerrisi, Ilona E. Suhanda, Elisabeth Bouvet, Sylvie Lariven, and Pauline Jeanmougin
Author affiliation: Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France (T. Delory); Antibioclic Steering Committee, Paris, France (T. Delory, J. Le Bel, E. Bouvet, S. Lariven, P. Jeanmougin); Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris (T. Delory, R. Metras, C. Guerrisi, I.E. Suhanda); Université Paris Cité, Paris (J. Le Bel); Université Paris Cité et Université Sorbonne Paris Nord, INSERM, Paris (J. Le Bel); Université de Nantes, Nantes, France (P. Jeanmougin)

Main Article

Table

Prescription data requests within the Antibioclic computerized decision support system for community-acquired pneumonia, France, 2018–2023*

Quarter No. requests/1,000 population
 2023 vs. 2018 relative risk (95% CI)
2018 2019 2020 2021 2022 2023
Overall
1 126.1 117.9 102.9 59.0 78.8 95.9 0.76 (0.75–0.77)
2 74.2 73.6 35.4 51.4 72.0 67.5 0.91 (0.90–0.92)
3 68.0 62.1 37.7 53.7 57.9 69.9 1.03 (1.02–1.04)
4
 99.9
 100.7
 47.9
 89.7
 104.4
 165.4
 1.66 (1.64–1.67)
Adults
1 135.5 120 99.4 51.9 80.2 107.9 0.80 (0.79–0.80)
2 73.9 73.4 35.9 47.4 74.1 68.9 0.93 (0.92–0.94)
3 65.7 60.2 37.8 53.4 57.7 63.8 0.97 (0.96–0.98)
4
 93.4
 95.5
 48.0
 86.3
 107.0
 138.0
 1.48 (1.46–1.49)
Children
1 94.6 110.8 116.5 84.8 74.0 60.2 0.64 (0.62–0.65)
2 75.1 74.5 31.6 67.8 65.3 62.8 0.84 (0.82–0.85)
3 77.7 70.3 37.1 55.1 58.7 94.0 1.21 (1.18–1.24)
4 119.9 117.0 47.2 99.1 98.6 223.6 1.87 (1.84–1.89)

*The rate of community-acquired pneumonia sharply decreased in all groups after introduction of nonpharmaceutical interventions for the COVID-19 pandemic (from the second quarter of 2020).

Main Article

1These co–primary authors contributed equally to this work.

Page created: October 07, 2024
Page updated: October 22, 2024
Page reviewed: October 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external